Immunotherapeutic compositions for the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/385 (2006.01) A61K 9/107 (2006.01) A61K 39/00 (2006.01) A61P 25/28 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2739318

A safe and effective vaccine to prevent, slow, halt or reverse progression of Alzheimer's disease in human patients is disclosed. The vaccine includes A.beta.1-42 or an beta amyloid self epitope (e.g. A.beta.1-15, or other 7-mer or 15-mer peptide epitopes derived from A.beta.1-42) conjugated to an immunogenic carrier (e.g. DT) formulated in a water-in-oil Th2- biased adjuvant/delivery system.

L'invention concerne un vaccin sûr et efficace pour prévenir, ralentir, stopper ou inverser l'évolution de la maladie d'Alzheimer chez des patients humains. Le vaccin comprend  Aß1-42 ou un auto-épitope de bêta-amyloïde (par exemple, Aß1-15, ou d'autres épitopes peptidiques 7-mères ou 15-mères dérivés de Aß1-42) conjugué à un support immunogène (par exemple DT) formulé dans un adjuvant/système de délivrance à biais Th2 eau-dans-l'huile.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunotherapeutic compositions for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapeutic compositions for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic compositions for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1453776

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.